Casas-Fernández C, Domingo-Jiménez R
Sección de neuropediatría, Hospital Universitario Virgen de la Arrixaca, El Palmar, España.
Rev Neurol. 2002 Sep;35 Suppl 1:S96-S100.
Tiagabine (TGB) is an anti epileptic drug whose mechanism of action is due to a reduction in the neurone and astrocyte uptake of gamma aminobutyric acid (GABA), causing its concentration at the synapse to be increased.
We analyze the most usual pharmacokinetic and pharmacodynamic characteristics of TGB, considering current therapeutic indications showing its increased use in seizures and partial epileptic syndromes. We also assess the adverse effects described, with special reference to the results obtained by the Spanish group investigating TGB, in a large number of patients with a wide range of ages. Finally we review the occurrence of status epilepticus induced by using TGB.
It is defined as a gabaergic drug which is well tolerated and causes no visual field reduction. It may be used in epilepsies and epileptic syndromes which can be treated with it.
噻加宾(TGB)是一种抗癫痫药物,其作用机制是减少神经元和星形胶质细胞对γ-氨基丁酸(GABA)的摄取,导致其在突触处的浓度增加。
我们分析了TGB最常见的药代动力学和药效学特征,考虑到当前的治疗适应症表明其在癫痫发作和部分癫痫综合征中的使用增加。我们还评估了所描述的不良反应,特别参考了西班牙研究TGB的小组在大量不同年龄段患者中获得的结果。最后,我们回顾了使用TGB引起癫痫持续状态的情况。
它被定义为一种耐受性良好且不会导致视野缩小的γ-氨基丁酸能药物。它可用于可用其治疗的癫痫和癫痫综合征。